You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 271 No. 7, February 16, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (102)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Molecular Predictors of Cognitive Involvement in Female Carriers of Fragile X Syndrome

Annette K. Taylor, MS, PhD; John F. Safanda; Majilinde Z. Fall, MA; Cindy Quince, MS; Kirsten A. Lang; Claire E. Hull; Isabelle Carpenter, BSN; Louise W. Staley, MS; Randi J. Hagerman, MD

JAMA. 1994;271(7):507-514.


Abstract

Objective.
—Fragile X syndrome is caused by a mutation involving expansion of a CGG trinucleotide repeat segment in the fragile X mental retardation—1 (FMR1) gene on the long arm of the X chromosome. This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation— number of CGG repeats, methylation status, and X inactivation ratio—on the cognitive involvement of female carriers of fragile X syndrome.

Design.
—Retrospective study with new DNA analysis of known female carriers of fragile X syndrome.

Setting.
—Molecular studies were conducted in a university-based DNA diagnostic laboratory. Patients were originally ascertained through a regional fragile X clinic in a university-affiliated pediatric hospital.

Patients.
—Forty-eight female carriers of fragile X syndrome were studied, including 22 with a premutation (a small expansion to approximately 50 to 200 CGG repeats), 23 with a full mutation (a full expansion to >200 CGG repeats), and three with both types of mutations (mosaics).

Results.
—Median IQ score was significantly lower for females with a full mutation than for females with a premutation. No significant relationship was found between IQ score and number of CGG repeats or percentage methylation of the mutant allele within each mutation category. In addition, no significant relationship was found between IQ score and the proportion of normal FMR1 alleles on the active X chromosome in the carrier female group as a whole or in either mutation subgroup. Comparisons of leukocytes and saliva-borne epithelial cells in certain full-mutation carriers revealed striking differences in FMR1 mutation sizes.

Conclusions.
—Mutation category remains the most important predictor of affectedness in female carriers of fragile X syndrome. Our data do not support use of the proportion of normal FMR1 alleles on the active X chromosome as a predictor of cognitive involvement in female carriers with full mutations. Individual tissue-specific differences exist in the heterogeneous sizes of full mutations and in the presence of premutation/full-mutation mosaicism.

(JAMA. 1994;271:507-514)



Author Affiliations

From the UCHSC DNA Diagnostic Laboratory, Department of Pediatrics (Dr Taylor, Mr Safanda, and Mss Fall, Quince, and Lang), and the Department of Pediatrics (Dr Hagerman), University of Colorado Health Sciences Center, and the Child Development Unit, The Children's Hospital (Mss Hull, Carpenter, and Staley and Dr Hagerman), Denver, Colo.


Footnotes

Reprint requests to UCHSC DNA Diagnostic Laboratory, Department of Pediatrics, University of Colorado Health Sciences Center, C-233, 4200 E Ninth Ave, Denver, CO 80262 (Dr Taylor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
Jacquemont et al.
JAMA 2004;291:460-469.
ABSTRACT | FULL TEXT  

FMRP expression studies in blood and hair roots in a fragile X family with methylation mosaics
de Vries et al.
J. Med. Genet. 2003;40:535-539.
FULL TEXT  

Predictive testing for cognitive functioning in female carriers of the fragile X syndrome using hair root analysis
Willemsen et al.
J. Med. Genet. 2003;40:377-379.
FULL TEXT  

Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction
Brunberg et al.
Am. J. Neuroradiol. 2002;23:1757-1766.
ABSTRACT | FULL TEXT  

The Influence of Environmental and Genetic Factors on Behavior Problems and Autistic Symptoms in Boys and Girls With Fragile X Syndrome
Hessl et al.
Pediatrics 2001;108:e88-88.
ABSTRACT | FULL TEXT  

Functional Neuroanatomy of Visuospatial Working Memory in Fragile X Syndrome: Relation to Behavioral and Molecular Measures
Kwon et al.
Am. J. Psychiatry 2001;158:1040-1051.
ABSTRACT | FULL TEXT  

A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA
Tassone et al.
J. Med. Genet. 2001;38:453-456.
ABSTRACT | FULL TEXT  

Twin sisters, monozygotic with the fragile X mutation, but with a different phenotype
Willemsen et al.
J. Med. Genet. 2000;37:603-604.
ABSTRACT | FULL TEXT  

Dilemmas in counselling females with the fragile X syndrome
de Vries et al.
J. Med. Genet. 1999;36:167-170.
ABSTRACT | FULL TEXT  

Fragile X Syndrome: Improving Understanding and Diagnosis
Caskey
JAMA 1994;271:552-553.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.